Medical polyoxymethylene (POM) is a non-toxic material and can be formulated in different colors, which makes it popular among medical device manufacturers. Moreover, it is easily moldable and molded into shape by injection or extrusion methods. It is a cost-effective material that is widely used in the manufacture of various medical devices and equipment. The increasing population with diabetes, coupled with the growing awareness about the use of this polymer in medical equipment is driving growth of medical polyoxymethylene (POM) market.
Market expansion will be fueled by rising demand for drug contact and delivery applications. Due to ongoing innovation in the market for medicine delivery systems, the medical POM sector is expanding. POM is a common medical plastic used in the manufacture of many different medical devices, including intraocular lenses, bone cement, cranial implants, and so on. Strongly elastomeric in nature, this material may be stretched and then compressed back into its original form. It is a well-liked substance for making prosthesis since it is inexpensive to create and reusable, which lowers production costs. Growth in the medical POM market will be fueled by the expanding medical device sector.
From 2023 to 2030, there is expected to be a compound annual growth rate (CAGR) of 3.37% for the global Medical Polyoxymethylene (POM) Market.
Top Companies in the Medical Polyoxymethylene Industry:
BASF SE
BASF SE is a European multinational corporation that is the world's largest chemical producer. It was established in 1865 and has its headquarters in Ludwigshafen, Germany. It is present in over 80 countries. By changing its European direct business for Ultraform® (POM) in June 2023, BASF will transfer the sales process to its long-standing, dependable business partners, ALBIS and Ultrapolymers Group, with effect from October 1, 2023. As it is, Ultraform® is a crucial component of BASF's engineering plastics line. By retaining Ultraform® R&D in-house, BASF can continue to provide its customers the benefits of its innovations and in-depth expertise, particularly when it comes to solving technical problems.
Celanese Corporation
Celanese Corporation was established in 1918 and has its headquarters in New York, USA. It has operations in 11 nations. At Medtec China 2023 in Suzhou, China, in June 2023, Celanese Corporation, a multinational speciality materials and chemical company, displayed an expanded array of polymer solutions for the healthcare market. In addition to its wide, tried-and-trued selection of medical plastics, Celanese also offers Zytel® Resin, Hytrel® TPC, Crastin® PBT, and MicromaxTM Electronic Inks and Paste. This is the result of the 2022 acquisition of the majority of DuPont's Mobility & Materials (M&M) division.
